IDO (indolamine 2,3-dioxygenase) expression and function in the CNS.

Area of Science:

• Immunology
• Neuroscience
• Cell Biology

Background:

• The placenta, an allograft, requires immune privilege to avoid rejection.
• Immune privilege protects tissues like the brain, eyes, and gonads from inflammation-mediated injury.
• Indoleamine 2,3-dioxygenase (IDO) is vital for placental immune privilege by inhibiting T cell proliferation via tryptophan catabolism.

Purpose of the Study:

• To investigate the role of IDO in suppressing inflammatory responses within the central nervous system (CNS).
• To determine if IDO expression and function in the CNS mirror its role in placental immune privilege.
• To assess the impact of IDO inhibition on T cell-mediated autoimmune diseases in the CNS.

Main Methods:

• RT-PCR and Western blot analysis to detect IDO expression in astrocytes and microglia.
• In vitro and in vivo experiments with pro-inflammatory cytokine interferon-gamma.
• Blockade experiments using 1-methyl-DL-tryptophan, an IDO inhibitor, in a mouse model of experimental autoimmune encephalomyelitis (EAE).

Main Results:

• Astrocytes and microglia express IDO upon activation with interferon-gamma.
• IDO inhibition significantly exacerbated EAE, indicating a protective role for IDO in the CNS.
• IDO appears to limit antigen-specific immune responses in the CNS during inflammation.

Conclusions:

• IDO plays a critical role in maintaining immune privilege within the CNS.
• IDO acts as a self-protection mechanism in the CNS by regulating inflammatory responses.
• Targeting IDO could have implications for treating CNS inflammatory and autoimmune diseases like multiple sclerosis.